Access to Infrastructure & R&D Support service

Bioanalytical Readiness for First-in-Human Studies

Provided by Anapharm Bioanalytics - Anapharm Europe S.L.U. · Spain

Service description

This service supports biotechnology and pharmaceutical companies preparing bioanalytical strategies and assays for First-in-Human (FIH) and early clinical development programmes. The service includes bioanalytical support for pharmacokinetics (PK), immunogenicity (ADA/NAb), pharmacodynamics (PD) and biomarker analysis for small molecules and biologics. Activities may include assay qualification, method transfer, analytical strategy discussions and preparation for regulated bioanalytical studies supporting Phase 1 readiness. The objective of the service is to help innovators reduce technical and regulatory risks before entering clinical development while ensuring robust and reliable bioanalytical approaches aligned with programme needs. Services are adapted to each project’s modality, development stage and regulatory context, combining scientific expertise, quality-focused execution and responsive project management. The service is delivered through close interaction with the sponsor team and can support both exploratory and regulated development activities.

Timelines and project execution plans are established individually according to regulatory requirements, assay readiness, study scope and sponsor timelines. Availability may depend on laboratory scheduling, analytical complexity and availability of required materials and reference standards.

← Back to Access to Infrastructure & R&D Support services